Condition
Hemangiomas
Total Trials
4
Recruiting
0
Active
0
Completed
4
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
25%
1 trials in Phase 3/4
Results Transparency
0%
0 of 4 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
1Total
P 3 (1)
Trial Status
Completed4
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT00576888Completed
Registry for Vascular Anomalies Associated With Coagulopathy
NCT00866827CompletedPrimary
Airway Vascular Lesions
NCT00312520Phase 3CompletedPrimary
Pulse Steroids Versus Oral Steroids in Problematic Hemangiomas of Infancy
NCT00577213CompletedPrimary
Diagnosis of Hemangiomas and Vascular Malformations
Showing all 4 trials